Resolution Therapeutics is developing regenerative macrophage therapies to transform outcomes for people with inflammatory and fibrotic diseases. The Company is built upon more than a decade of work in the Founders’ laboratories at the University of Edinburgh, characterising the role of regenerative macrophages in organ repair, including the liver, both in the pre-clinical and clinical settings. Resolution’s world class team is focused on discovering, developing, manufacturing and taking to market regenerative macrophage therapies based on its proprietary platform of macrophage biology, cell engineering and manufacturing processes.
Resolution is a clinical-stage biotechnology company pioneering Regenerative Macrophage Therapy in inflammatory and fibrotic diseases.
MORE INFO +Our work builds on more than a decade of cutting-edge research demonstrating the therapeutic potential of macrophages in inflammatory and fibrotic diseases.
MORE INFO +Interested in working on cutting-edge science in a fast-paced environment? We’d love to hear from you
MORE INFO +All the latest scientific publications underpinning our work by our scientific founders & groups.
MORE INFO +
Resolution is at the forefront of a new kind of cell therapy. We’re treating inflammatory organ disease with macrophages, the cells that the body uses to resolve injury and heal wounds. Our work builds on a huge body of science understanding the role of macrophages as orchestrators of the wound healing process; coupled with our world-leading founders, a top-quality scientific staff and proprietary insight into macrophage biology and manufacturing, we are poised to improve the lives of countless patients worldwide.
